Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ganten

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 24, 2013
Monitoring targeted therapy using dual-energy CT: semi-automatic RECIST plus supplementary functional information by quantifying iodine uptake of melanoma metastasesM Uhrig, M Sedlmair, H P Schlemmer, et al.
Oncology|April 15, 2015
Pancreatic Atrophy in Hepatocellular Carcinoma Patients Receiving Long-Term Treatment with SorafenibMaria-Katharina Ganten, Max Schuessler, Thomas Bruckner, et al.
Der Radiologe|January 29, 2003
[Follow up of Crohn's disease under therapy with hydro-MRI]M Ganten, J Encke, P Flosdorff, et al.
Oncology|October 19, 2012
Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinomaRonald Koschny, Daniel Gotthardt, Christiane Koehler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|February 21, 2009
Intracranial dissection during carotid endarterectomy treated by carotid stentingN Attigah, M Ganten, A Hyhlik-Dürr, et al.
Pathology, Research and Practice|December 4, 2009
Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel diseaseSylvia Brost, Ronald Koschny, Jaromir Sykora, et al.
European Journal of Clinical Investigation|January 16, 2007
Helicobacter pylori-induced apoptosis in T cells is mediated by the mitochondrial pathway independent of death receptorsT M Ganten, E Aravena, J Sykora, et al.
Pathology, Research and Practice|November 26, 2013
Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infectionSylvia Brost, Anna Zimmermann, Ronald Koschny, et al.
European Journal of Radiology|December 19, 2012
Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenibXu Dai, Heinz-Peter Schlemmer, Bernhard Schmidt, et al.
Hepatology (Baltimore, Md.)|July 23, 2005
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAILTom M Ganten, Ronald Koschny, Tobias L Haas, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 24, 2013
Monitoring targeted therapy using dual-energy CT: semi-automatic RECIST plus supplementary functional information by quantifying iodine uptake of melanoma metastasesM Uhrig, M Sedlmair, H P Schlemmer, et al.
Oncology|April 15, 2015
Pancreatic Atrophy in Hepatocellular Carcinoma Patients Receiving Long-Term Treatment with SorafenibMaria-Katharina Ganten, Max Schuessler, Thomas Bruckner, et al.
Der Radiologe|January 29, 2003
[Follow up of Crohn's disease under therapy with hydro-MRI]M Ganten, J Encke, P Flosdorff, et al.
Oncology|October 19, 2012
Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinomaRonald Koschny, Daniel Gotthardt, Christiane Koehler, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|February 21, 2009
Intracranial dissection during carotid endarterectomy treated by carotid stentingN Attigah, M Ganten, A Hyhlik-Dürr, et al.
Pathology, Research and Practice|December 4, 2009
Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel diseaseSylvia Brost, Ronald Koschny, Jaromir Sykora, et al.
European Journal of Clinical Investigation|January 16, 2007
Helicobacter pylori-induced apoptosis in T cells is mediated by the mitochondrial pathway independent of death receptorsT M Ganten, E Aravena, J Sykora, et al.
Pathology, Research and Practice|November 26, 2013
Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infectionSylvia Brost, Anna Zimmermann, Ronald Koschny, et al.
European Journal of Radiology|December 19, 2012
Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenibXu Dai, Heinz-Peter Schlemmer, Bernhard Schmidt, et al.
Hepatology (Baltimore, Md.)|July 23, 2005
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAILTom M Ganten, Ronald Koschny, Tobias L Haas, et al.
Pageof 5